Estar Medical is a world leader in Platelet-Rich Plasma (PRP) and autologous cell therapy technologies and is proud to be at the forefront of regenerative medicine companies with our unique patented FDA and CE technology that delivers progressive non-surgical healing treatment in multiple medical applications such as: Aesthetics, Orthopedics, Wound Management, Dental, Cardiology, Ophthalmology, Veterinary and more.
Complementary Products
News & Events
Jan 30, 2020
IMCAS World Congress 2020 January 30 – February 2 in Paris
Estar medical is delighted to take part in the IMCAS congress that has targeted effective…
Aug 15, 2019
Regenlab is in Breach of UK Court Orders Following Revocation of its PRP Patent
Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High…
Jun 7, 2019
5CC Aesthetics Conference – Barcelona, Spain – August 2019
Estar Medical is delighted to take part in the 5CC aesthetics conference and exhibition. One…
Jun 6, 2019
TOBI 10th Annual PRP & Regenerative Medicine Symposium, Workshops & Cadaver Labs
Estar Medical is delighted to take part in the TOBI congress - a major yearly…
May 21, 2019
European Patent Office revoked Regenlab PRP patent
Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent…
Jun 7, 2019
FACE – Facial Aesthetic Conference & Exhibition, London, UK
Estar Medical is delighted to take part in the FACE conference and exhibition. UK's premier…